Careium

23,50 SEK

-0,42 %

Mindre end 1K følgere

CARE

First North Stockholm

Hardware Manufacturer

Technology

-0,42 %
+15,76 %
-5,62 %
-1,26 %
-13,60 %
-14,86 %
+54,10 %
-
-26,79 %

Careium offers security solutions such as security alarms, smart sensors and digital visits, with its own alarm center that is staffed 24/7. The product offering includes security alarms, sensors and accessories such as cameras and electronic locks. The company targets private individuals, municipalities and care organizations, and is active in several countries in Europe. The company is headquartered in Malmö, Sweden.

Læs mere
Markedsværdi
571,67 mio. SEK
Aktieomsætning
102,84 t SEK
Omsætning
854,1 mio.
EBIT %
5,76 %
P/E
17,67
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
10.7
2026

Delårsrapport Q2'26

22.10
2026

Delårsrapport Q3'26

ViserAlle indholdstyper
Eksterne analyser

Careium: Relief around the corner - ABG

* Underlying development looks promising * We raise our '26-'28 EBIT estimates by 3-1% * Share is trading at 10x-7x '26e-'28e EV/EBIT Margins not as soft as expected Q1 came in 2% (SEK 4m) above our expectations on sales, for a solid organic growth of...

Careium
Eksterne analyser

Careium: Strong growth makes up for elevated costs - ABG

* Q1 sales 2% above our ests. at SEK 220m, for 11% org. growth * Adj. EBIT SEK 13m vs. ABGSCe 9m * Trading at 10x-7x '26e-'28e EV/EBITA adj. A strong Q1 given ongoing headwinds Q1 came in slightly above expectations on sales, and materially above expectations...

Careium

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Eksterne analyser

Careium: Entering a growth-focused period - ABG

* Q1e: 10% organic sales growth, 4% adj. EBITA margin * We cut our EBITA estimates by 7-2% * Trading at 9x '26e EV/EBITA Q1e: strong organic growth, but soft margins We expect Q1 to be strong in terms of organic growth, as Careium will no longer face...

Careium
Eksterne analyser

Careium: Bittersweet outlook on 2026 - ABG

* Margin pressure to remain in H1'26e * We cut our '26-'27 EBIT estimates by 15% and 9% * Share is trading at 9x-7x '26e-'27e EV/EBIT EBIT materially lower than anticipated Careium delivered solid sales in Q4, with organic growth of 6.3% despite tough...

Careium
Eksterne analyser

Careium: Margin pressure to remain in H1'26 - ABG

* Q4 sales 4% above our ests. at SEK 231m, for 6% org. growth * Adj. EBIT SEK 8m vs. ABGSCe 22m * Trading at 8x-7x '26e-'27e EV/EBITA adj. Solid sales but material opex growth Q4 came in above expectations on sales, but materially below on EBIT. Careium...

Careium
Eksterne analyser

Careium: At the end of a rough stretch - ABG

* Q4e: 4% organic sales growth, 11% adj. EBITA margin * We cut estimates on the downgraded outlook * Trading at 8x '26e adj. EV/EBITA The final quarter of a tough year We expect Q4 sales and adj. EBITA of SEK 227m and SEK 24m, respectively, corresponding...

Careium
Eksterne analyser

Careium: Downgrades '25e outlook - ABG

* Careium states that it will not meet FY'25 outlook...* ... Implying FY'25 sales growth of -2%* Mechanical effect on '25 estimates imply 4% cut on EBITCareium will not meet its '25e outlookCareium has downgraded its full-year outlook, which was previously...

Careium
Eksterne analyser

Careium: Careful steps forward - ABG

* Q3: Softer than expected, but back to growth* We cut our sales and adj. EBITA estimates* Share is trading at 11x-7x '25e-'26e EV/EBITA adj.Softer than expectedCareium delivered solid sales in Q3, with organic growth of 9.4% compared to -8% in Q3'24...

Careium
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.